Additional information
| Active substance | Doxazosin |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Not specifically associated with regular lab tests, but blood pressure should be monitored |
| Also known as | Doxazosin mesylate |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Reduces both systolic and diastolic blood pressure |
| Trade name | Cardura, others |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Chemical name | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazine |
| Formula | C23H25N5O5 |
| Substance class | Alpha-1 adrenergic receptor blocker |
| Main action | Lowers blood pressure by relaxing blood vessels |
| Half-life | 22 hours |
| Dosage (medical) | 1-16 mg per day, depending on the condition being treated |
| Dosage (sports) | Not applicable |
| Effects | Reduces blood pressure and improves symptoms of enlarged prostate |
| Side effects | Dizziness, fatigue, headache, hypotension, palpitations |
| Use in sports | Not typically used in sports |
| Manufacturer | Pfizer |
Reviews
There are no reviews yet.